Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

José Manuel Trigo

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Medicina Clinica|April 3, 2008
[Current strategies in the treatment of renal-cell cancer: targeted therapies]José Manuel Trigo, Joaquim Bellmunt
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 4, 2009
MDMA reinstates cocaine-seeking behaviour in miceJosé Manuel Trigo, Maria Juliana Orejarena, Rafael Maldonado, et al.
Psychopharmacology|December 20, 2005
A reliable model of intravenous MDMA self-administration in naïve miceJosé Manuel Trigo, Fany Panayi, Guadalupe Soria, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 16, 2012
Practical guidelines for dose individualization of anticancer targeted drugsMaría Isabel Sáez, Cristina Quero, José Manuel Trigo, et al.
Psychopharmacology|January 11, 2008
MDMA modifies active avoidance learning and recall in miceJosé Manuel Trigo, Araceli Cabrero-Castel, Fernando Berrendero, et al.
Neuroscience and Biobehavioral Reviews|February 23, 2010
Neurobiological mechanisms involved in nicotine dependence and reward: participation of the endogenous opioid systemFernando Berrendero, Patricia Robledo, José Manuel Trigo, et al.
Drug and Alcohol Dependence|December 1, 2009
The endogenous opioid system: a common substrate in drug addictionJosé Manuel Trigo, Elena Martin-García, Fernando Berrendero, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 27, 2010
SEOM clinical guidelines for the treatment of non-small-cell lung cancer: an updated editionJosé Manuel Trigo Pérez, Pilar Garrido López, Enriqueta Felip Font, et al.
Pharmacology, Biochemistry, and Behavior|July 12, 2005
Evaluation of the anticocaine monoclonal antibody GNC92H2 as an immunotherapy for cocaine overdoseM Rocío A Carrera, José Manuel Trigo, Peter Wirsching, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 4, 2012
Tyrosine kinase inhibitors and drug interactions: a review with practical recommendationsBella Pajares, Esperanza Torres, José Manuel Trigo, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Medicina Clinica|April 3, 2008
[Current strategies in the treatment of renal-cell cancer: targeted therapies]José Manuel Trigo, Joaquim Bellmunt
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 4, 2009
MDMA reinstates cocaine-seeking behaviour in miceJosé Manuel Trigo, Maria Juliana Orejarena, Rafael Maldonado, et al.
Psychopharmacology|December 20, 2005
A reliable model of intravenous MDMA self-administration in naïve miceJosé Manuel Trigo, Fany Panayi, Guadalupe Soria, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 16, 2012
Practical guidelines for dose individualization of anticancer targeted drugsMaría Isabel Sáez, Cristina Quero, José Manuel Trigo, et al.
Psychopharmacology|January 11, 2008
MDMA modifies active avoidance learning and recall in miceJosé Manuel Trigo, Araceli Cabrero-Castel, Fernando Berrendero, et al.
Neuroscience and Biobehavioral Reviews|February 23, 2010
Neurobiological mechanisms involved in nicotine dependence and reward: participation of the endogenous opioid systemFernando Berrendero, Patricia Robledo, José Manuel Trigo, et al.
Drug and Alcohol Dependence|December 1, 2009
The endogenous opioid system: a common substrate in drug addictionJosé Manuel Trigo, Elena Martin-García, Fernando Berrendero, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 27, 2010
SEOM clinical guidelines for the treatment of non-small-cell lung cancer: an updated editionJosé Manuel Trigo Pérez, Pilar Garrido López, Enriqueta Felip Font, et al.
Pharmacology, Biochemistry, and Behavior|July 12, 2005
Evaluation of the anticocaine monoclonal antibody GNC92H2 as an immunotherapy for cocaine overdoseM Rocío A Carrera, José Manuel Trigo, Peter Wirsching, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 4, 2012
Tyrosine kinase inhibitors and drug interactions: a review with practical recommendationsBella Pajares, Esperanza Torres, José Manuel Trigo, et al.
Pageof 4